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Abstract
Background: Bubble continuous positive airway pressure (CPAP) has been shown to
be effective in supporting breathing in newborns with respiratory distress. The
factors that influence implementation in resource-constrained settings remain
unclear. The objective of this review is to evaluate the barriers and facilitators of
CPAP implementation for newborn care at sub-Saharan African health facilities and
how different facility levels and types of bubble CPAP systems may impact utilization.
Methods: A systematic search (database inception to July 2019) was performed on
MEDLINE Ovid, EMBASE, CINAHL, The Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library), the WHO Regional Database for Africa, African
Index Medicus (AIM), African Journals Online, grey literature and the references of
relevant articles. Studies that met the inclusion criteria (primary research, bubble
CPAP implementation with neonates ≤ 28 days old at a health facility in sub-Saharan
Africa) were included in the review and assessed with National Heart, Lung, and
Blood Institute of the National Institutes of Health (NIH) quality assessment tools. The
review protocol was published to PROSPERO (CRD42018116082).
Results: Seventeen studies were included in the review. Reliable availability of
equipment, effectively informing and engaging caregivers and staffing shortages
were frequently mentioned barriers to the implementation of bubble CPAP.
Understaffed neonatal units and high turnover of nurses and doctors compromised
effective training. Provider-to-provider clinical mentorship models as well as
affordability and cost-effectiveness of innovative bubble CPAP systems were
identified as frequently mentioned facilitators of implementation.
Conclusions: With a strong recommendation by the World Health Organization for
its use with premature infants with respiratory distress, it is important to understand
the barriers and facilitators that can inform the implementation of bubble CPAP.
More research is needed into health system factors that can support or impede the
use of this potentially promising intervention.
Keywords: Bubble continuous positive airway pressure (CPAP), Sub-Saharan Africa,
Neonates, Implementation, Low-resource settings
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to
the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The
images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise
in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright
holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated in a credit line to the data.
Kinshella et al. Public Health Reviews            (2020) 41:6 
https://doi.org/10.1186/s40985-020-00124-7
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by International Development Research Centre: IDRC Digital Library
Introduction
Globally, there have been significant declines in infant mortality but rates of neonatal
mortality are declining at a slower pace than among older infants and children [1]. Al-
though the third Sustainable Development Goal (SDG-3) aims to reduce under-five
mortality rates to fewer than 25 per 1000 live births and neonatal mortality rates to
fewer than 12 per 1000 by the year 2030, a recent study found that if the slow trend in
neonatal mortality reduction continues, only two out of the 31 sub-Saharan African
countries are predicted to achieve SDG-3 targets [2]. Among newborns in sub-Saharan
Africa, one in every 36 neonates die within the first month, a staggering inequality
compared to one in 333 in high-income countries (HICs) [3]. Preterm birth complica-
tions are a leading cause of neonatal death [1] and a review found that nine of the 11
countries globally with estimated preterm birth rates of 15% or more were in sub-
Saharan Africa [4]. With an estimated average pre-term birth rate at 12.3% across the
sub-Saharan Africa region (12.3%), there is a need to effectively address accompanying
complications in order to reduce the burden of neonatal deaths [1, 4]. Preterm new-
borns often have underdeveloped respiratory systems, with more than 50% of infants
born before 31 weeks gestation developing respiratory distress syndrome (RDS) [5].
Newborns with RDS can be managed effectively with breathing support, such as
mechanical ventilation or continuous positive airway pressure (CPAP), as well as sur-
factant replacement therapy [6]. CPAP is strongly recommended by the World Health
Organization (WHO) for the treatment of preterm newborns with RDS [7]. CPAP is a
simple, non-invasive form of respiratory support requiring less advanced technical ex-
pertise than mechanical ventilation, an invasive procedure involving endotracheal in-
tubation or tracheostomy tube insertion [8–11]. Although CPAP is widely
recommended for managing respiratory distress and has been utilized in high-income
countries (HICs) for decades, hospitals in resource-limited settings still experience chal-
lenges in its implementation. Conventional CPAP machines, while less costly than
mechanical ventilation, are still not economically sustainable in most low- and middle-
income countries (LMICs). Bubble CPAP provides a potential solution, as a safe and
cost-effective way for delivering CPAP in LMICs [8]. Bubble CPAP safely regulates air
pressure by submerging the end of the expiration tubing into water, with the depth of
the tube in the water determining the pressure in the system [8–12]. This maintains a
volume of air in the lungs (functional residual lung capacity) to support the newborn’s
spontaneous breathing [8–12]. A systematic review demonstrated that when bubble
CPAP is utilized effectively, it can reduce the need for mechanical ventilation by 30–
50% with no increase in mortality [8].
Although there is evidence suggesting that bubble CPAP is an efficacious, safe, cost-
effective device to support neonatal breathing, there is still a lack of knowledge regard-
ing factors influencing implementation in limited-resource settings [13]. Consequently,
the primary objective of this systematic review is to evaluate known barriers and facili-
tators to the implementation, utilization and sustainability of bubble CPAP for neonates
at health facilities in sub-Saharan Africa. Secondary objectives of the review explore the
varying types of devices and the different hospital settings where bubble CPAP are
used. The secondary objectives are firstly, to scope and document the different types of
bubble CPAP and facility levels implementing bubble CPAP in sub-Saharan Africa and
secondly, to evaluate barriers and facilitators of bubble CPAP for neonates at health
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facilities in sub-Saharan Africa by health facility and device type. The third secondary
objective is to understand the efficacy and safety of bubble CPAP for neonates at health
facilities in sub-Saharan Africa by health facility and device type. Based on the strong
recommendation by the WHO, it is important to understand the barriers and facilita-
tors that can inform effective bubble CPAP implementation in resource-constrained
settings such as in many sub-Saharan hospitals, where bubble CPAP therapy is a critical
need.
Methodology
Searches were undertaken on MEDLINE Ovid, EMBASE, CINAHL, The Cochrane
Central Register of Controlled Trials (CENTRAL, The Cochrane Library), the WHO
Regional Database for Africa, African Index Medicus (AIM) and the African Journals
Online database to July 2019 by the primary (MWK) reviewer, with no limits applied to
the year of publication. Based on the PICOS research framework (Table 1), search
terms broadly included infants, neonates, respiratory distress syndrome (RDS), sub-
Saharan Africa and bubble CPAP (see Additional file 1). Results were then manually
screened for implementation, utilization and health facility to prevent missing relevant
studies in the original search that did not include these keywords. Grey literature, in-
cluding programme reports and dissertations, was searched on Google and Google
Scholar and conference proceedings authors were contacted directly by the primary re-
searcher. Reference lists of all primary studies were reviewed for additional references.
Titles and/or abstracts of studies were independently screened by the primary and
secondary reviewers (MWK and CRW) according to the eligibility criteria (Table 2).
We included studies that self-identified as a bubble CPAP device though recognize that
a recent study has shown that a low-cost standalone system, Pumani, does not fully fol-
low the mechanisms of a bubble CPAP device [14]. However, because this study focuses
on implementation factors and Pumani has been updated in response to the study by
Falk and colleagues, we have elected to include it in our review as the broader picture
of health system barriers and facilitators remain similar. Discussions of efficacy and
safety will present separate data for Pumani device. Barriers were defined as implemen-
tation factors that hindered CPAP use within local contexts while facilitators were im-
plementation factors that supported CPAP use as self-reported by studies. Reviewers
compared their results to reach consensus and ties were resolved by a third reviewer
(THM). Full text of these studies was then independently reviewed by the primary and
secondary reviewers, with the third reviewer (THM) providing an independent assess-
ment in any disagreements regarding eligibility until consensus was reached. Details
about the study method, sample size, country, facility type, bubble CPAP type,
Table 1 PICOS research framework
Population Neonates ≤ 28 days
Intervention Bubble CPAP
Context Secondary or tertiary health facilities in sub-Saharan Africa
Comparisons Non-bubble CPAP, other respiratory support interventions, no respiratory support interventions,
N/A
Outcome Enablers and barriers of bubble CPAP, survival to discharge rates
Study All study designs
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outcomes, complications, barriers, and facilitators were extracted into a data extraction
sheet. The ROBINS-I tool was initially planned for quality assessment but its focus on
non-randomized studies was not suited to the diversity of studies found in the search.
The focus of the ROBINS-1 tool is on intervention studies [15], which was too narrow
of a scope to accommodate the variety of observational studies that highlight imple-
mentation aspects. The study quality assessment tools of the National Heart, Lung, and
Blood Institute of the National Institutes of Health (NIH) for quality assessment of case
series, observational cohort and cross-sectional studies, before-after studies with no
control group and controlled intervention studies were used to assess the quality of in-
cluded studies [16, 17]. The review protocol was published to PROSPERO
(CRD42018116082) [18].
Results
Seventeen studies that discussed using bubble CPAP at a health facility in sub-Saharan
Africa with neonates were found in the search (Fig. 1, Table 3). This included six case
studies or series of neonates who received bubble CPAP [19, 20, 22, 23, 29, 34], four
observational cohort or cross-sectional studies [26, 30, 31, 33], three uncontrolled
before-and-after studies [12, 25, 32] and four case-control intervention studies that
compared novel use of bubble CPAP systems or implementation components with local
Table 2 Eligibility criteria
Inclusion criteria Exclusion criteria
• Discussed implementation and/or utilization of self-
identified bubble CPAP systems with neonates (≤ 28
days old)
• At a health facility in sub-Saharan Africa
• Randomized controlled trials, quasi-experimental
studies, observational and exploratory studies, case
studies, economic evaluations, programme reports and
clinical charting
• Neonatal data not separated from older infants older
than 28 days, older children and/or adults
• Studies that do not specify bubble CPAP from other
forms of CPAP or neonatal respiratory support
systems
• Studies without primary data collection on using
bubble CPAP in a health facility
• Study protocols, literature reviews, conference
proceedings, letters to the editor, opinion papers,
editorials and abstracts
• Not in English
Fig. 1 PRISMA flow diagram
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Table 3 Studies included in the review
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Table 3 Studies included in the review (Continued)
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standards of existing care [5, 21, 24, 28]. All four case-control intervention studies were
quasi-experimental and there were no randomized controlled trials.
Of the 17 studies included in this review, six (35%) used improvised water bottle sys-
tems, five (29%) used low-cost standalone systems, two (12%) used commercial bubble
CPAP system and four (24%) did not describe the system used or covered a combin-
ation of different types of devices. Four out of the five low-cost standalone systems used
the Pumani bubble CPAP device, which was developed in Malawi [5, 23, 24, 26], and
one study used politeCPAP, which was recently developed in Nigeria [21]. DeVilbiss
IntelliPAP [28] and Fisher Paykel [32] bubble CPAP systems were the two commercial
versions used. Most studies were conducted in tertiary level hospitals (11 studies; 65%),
with four (24%) conducted in secondary level rural referral or district hospitals and two
(12%) included both tertiary and district hospitals. Studies were largely clustered in East
African countries, Malawi and Nigeria. All the studies were published 2011 or
afterwards.
Device characteristics
The device characteristics that promoted the use of bubble CPAP included the fact that
it was simple to use compared with mechanical ventilation and that it was affordable
and low maintenance [19, 20, 22]. Pricing ranged from US$2 for a low-cost, improvised
water bottle system made from locally available materials, US$350 for a low-cost stan-
dalone unit developed in Malawi, to US$2000 for a standalone unit including twin air
compressors, temperature-controlled gas delivery and integrated pulse oximeter devel-
oped in Nigeria [5, 19–22, 27, 33].
Two studies, both from tertiary facilities in Nigeria, raised the concern that efficacy
of bubble CPAP may be limited to mild to moderate respiratory distress and less com-
plex cases [19, 20]. These studies found that the majority of the newborns that did not
respond to CPAP had a high Downes’ score, which marks respiratory distress severity,
and had a very (less than 1500 g) or extremely (less than 1000 g) low birthweight or
other severe conditions [19, 20]. Extremely low-birthweight newborns are at heightened
risk for neonatal hypothermia and one study demonstrated that a bubble CPAP system
with temperature-controlled gas delivery had the potential to reduce the risk of neo-
natal hypothermia, especially with this population [21].
Training and staffing
An important barrier for the implementation of bubble CPAP was around understaffing
of neonatal units. As discussed in five studies, a lack of adequate staffing may limit the
capacity for care, especially if existing workloads were already substantial [24, 25, 29,
32, 34]. An early study of bubble CPAP in Malawi found that there were only two
nurses available for an average of 30 neonates [34]. Understaffing was associated with
limited availability for training, which was compounded with other challenges such as
high turnover of nurses and doctors necessitating repeated trainings of new staff [25,
28, 30–32]. Consequently, studies noted gaps in the training that was available. A study
in Nigeria found that 44% of respondents were untrained in the use of bubble CPAP
even though the same respondents reported that CPAP was used in 72% of their facil-
ities [33].
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Additionally, four studies described challenges around motivation and leadership [25,
30–32]. Researchers from a study conducted in Ethiopia noted the challenge of poor
motivation as nurses did not appear to be interested in practising what they had
learned in trainings [25]. Lack of motivation was linked to poor accountability, under-
staffing and frequent rotations by medical and nursing leadership [25, 32]. Additionally,
one study found that local nurses did not understand English well, which presented a
communication barrier with doctors who conducted medical meetings and ward
rounds in English [25]. Good leadership by hospital management who perceived neo-
natal care as a priority was identified as an important facilitating factor for bubble
CPAP implementation in 19 tertiary level facilities across Kenya [30].
Four studies highlighted the importance of regular and interactive training and that it could
serve as a facilitator to implementation [24, 25, 28, 31]. The effective training used a wide
range of methods including comprehensive presentations on respiratory physiology, indica-
tions to initiate bubble CPAP, contraindications and monitoring complemented by instruc-
tional videos, the use of case examples, simulation scenarios with mannequins and real-time
supervision and utilization of bubble CPAP on an infant [24, 25, 28, 31]. Provider-to-provider
clinical mentorship models supported training efforts, especially when clinical mentors were
trained in how to train others to use bubble CPAP [28, 30, 31]. Experience sharing trips to ef-
fective neonatal units and intermittent refresher trainings were helpful in supporting know-
ledge and skill development; this built motivation and morale as health providers regarded it
as an investment in their professional capacities [25, 31]. One study recommended investing
by training the nurses who across profession generally remain on the ward compared to doc-
tors who may move around the hospital or between hospitals [25]. Another study recom-
mended resources be allocated to introducing long-term clinicians to reinforce training [32].
To build momentum and motivation, two studies used a combination of external consultants
with local clinicians to provide training [31, 34].
Initiation, monitoring and weaning
Four studies discussed barriers to commencement of CPAP [20, 23, 31, 34]. Challenges
around initiation highlighted that gaps in the correct identification of early/mild signs of
respiratory distress [31] and the reluctance of nurses to initiate CPAP due to short staffing
and/or desire to consult with a doctor first [34] were associated with a delay in initiating
bubble CPAP, which was ultimately associated with less optimal outcomes [5]. Three
studies further highlighted that regular monitoring is required to prevent and manage
complications, such as nasal prong-related complications and “CPAP belly syndrome” [5,
20, 23]. Additionally, two studies discussed the challenges around weaning, including
knowing when to wean, especially when human resources were limited [29], and the need
to monitor closely after weaning to ensure the neonate is not desaturating [19].
Decision aids were described as potential facilitators to bubble CPAP use, including a clin-
ical algorithm to aid in deciding to initiate [24] and using a respiratory severity score to moni-
tor respiratory distress [29]. No potential facilitators for the weaning process were presented.
Caregivers
Three studies, including two from Malawi and one from Kenya, discussed barriers to imple-
mentation around engaging caregivers [23, 26, 30]. Brown et al. found that parents in Malawi
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may be reluctant to allow infants to receive oxygen therapy because the need for oxygen was
considered to cause poor outcomes [23]. A qualitative study researching caregiver experiences
at a tertiary hospital in Malawi found that there were gaps in consenting parents before start-
ing bubble CPAP, particularly since there was limited visiting hours to the neonatal intensive
care unit (NICU) and caregivers often found their newborn already commenced on bubble
CPAP [26]. Information about bubble CPAP was poorly provided to all caregivers, including
the mother and close family members [26]. The caregivers’ experiences also shared concerns
on how bubble CPAP may complicate mother-infant interactions [26]. It was noted that
mothers were afraid to hold their infants because they were worried that they would not be
able to see their child’s face and that the device would interrupt skin-to-skin contact [26]. A
study from Kenya highlighted that peer support from the caregivers of newborns that had sur-
vived after being put on bubble CPAP was a particularly powerful opportunity to educate par-
ents and guardians who are unsure about the system [30].
Supplies and equipment
Three studies, all from Nigeria, discussed using appropriate and locally available equip-
ment as facilitators for bubble CPAP implementation [19, 20, 22]. Appropriate equip-
ment focused on nasal prongs and the importance of snug-fitting and soft nasal prongs
to prevent nasal damage [19, 20].
Five studies, however, also identified how a reliable supply and availability of equipment was
an implementation challenge [5, 23, 30, 32, 34]. Ancillary equipment, such as oxygen concen-
trators, was an issue; even though the low-cost standalone bubble CPAP model was developed
for low-resource settings and was low maintenance, the oxygen concentrators associated with
the device were not [5]. In one study, 40% of oxygen concentrators failed due to line voltage
spikes [5]. Cost of disposable nasal prongs was also identified as a barrier in resource-
constrained settings as was the availability of CPAP machines [5, 23, 34]. A Malawian study
by Kawaza et al. noted that 31% (n = 12) of the neonates died when the CPAP system was oc-
cupied and the newborn did not receive CPAP [5]. Studies also highlighted diversity on the
health landscape as different CPAP machines caused challenges in training, setup and main-
tenance [32]. A recent study from Kenya found that most bubble CPAP systems across the 19
tertiary level facilities evaluated were commercial versions donated by international partners.
These devices encountered problems with maintenance as donor projects completed and sup-
port was withdrawn [30]. Additionally, inadequate infrastructure was associated with lower
staff morale and motivation to use bubble CPAP [30] (Table 4).
Barriers and facilitators of bubble CPAP by health facility and device type
Across the multiple settings and device types, understaffed neonatal units, high turnover of
staff and low staff motivation and morale to use bubble CPAP were common barriers. Com-
mon facilitators were clinical mentorship and regular, interactive training. Decision aids to
support the initiation and monitoring respiratory distress were highlighted as facilitators in
secondary level facilities [24, 29]. Affordability was highlighted as a facilitator in both impro-
vised water bottle systems and low-cost standalone models [5, 20–22, 27]. Studies focusing on
improvised water bottle systems highlighted the benefit of being able to use locally available
materials to manufacture the bubble CPAP device, yet a perceived barrier remains because
most improvised water bottle systems and standalone models do not heat or humidify the air
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being provided to the newborn [5, 21, 23]. Additionally, low-cost standalone models
highlighted the benefit of low maintenance, while inadequate maintenance was cited as a bar-
rier especially for commercial models [5, 21, 30].
Efficacy and safety of bubble CPAP by health facility and device type
Nine of the 17 studies (53%) presented novel data on survival to discharge rates. Sur-
vival to discharge rates with bubble CPAP varied widely between studies, ranging from
Table 4 Implementation factors
Topic Facilitators Barriers
Device • Simple to use, affordable and low maintenance for
low-resource settings.
• A temperature-controlled gas circuit may reduce
the risk of hypothermia especially in extremely low-
birthweight babies.
• Efficacy may be limited to mild to
moderate respiratory distress and less
effective with severe cases.
Training
and staffing
• Regular and interactive training with intermittent
refresher trainings.
• Clinical mentorship with training on how to train
others to use bubble CPAP.
• Investing in nurses dedicated to the nursery.
• Clinicians that stay longer term in the nursery.
• Combination of external consultant with local
clinicians as trainers.
• Health facility management that prioritized
neonatal care.
• Understaffed neonatal units limit the
capacity for care.
• Staffing shortages exacerbated by
healthcare provider strikes in some
locations.
• High turnover of nurses and doctors
necessitated repeated training of new
staff.
• Lack of motivation and accountability.
• Gaps in training as many nurses and
doctors are untrained in bubble CPAP.
• Communication barriers between
doctors and nurses.
Initiation • Decision-making aided by clinical algorithm that is
clearly posted by the machine.
• Gaps in correct identification of early and
mild signs of distress.
• Reluctance of nurses to initiate while
short-staffed at night and without con-
sulting a clinician.
• Overtightening the chin strap can lead
to facial swelling.
Monitoring • Appropriate and regular monitoring.
• Monitoring with pulse oximetry.
• Monitoring respiratory distress with respiratory
severity score.
• Complications such as CPAP belly
syndrome and mucosal drying require
regular monitoring and actions to
prevent.
Weaning None discussed. • Knowing when to wean, especially when
resources are limited.
• A need to monitor closely after weaning
to ensure the infant is not desaturating.
Caregivers • Peer support from caregivers with positive
experiences with bubble CPAP use on their own
newborns.
• Local beliefs that the oxygen led to poor
outcomes.
• Poorly providing information to
caregivers and gaps in consenting
parents before starting bubble CPAP.
• Bubble CPAP may complicate mother-
infant interaction as mothers were afraid
to hold babies, unable to see their in-





• Appropriate snug-fitting nasal prongs.
• Soft nasal prongs.
• Use of locally available materials.
• Cost of disposable nasal prongs.
• Oxygen concentrators not always
available.
• CPAP machines not always available.
• Different machines cause challenges in
training, set up and maintenance.
• Poor equipment maintenance once
donors withdraw support.
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49 to 85% in tertiary hospitals [20, 22, 30, 34] and 42 to 85% in rural district level refer-
ral hospitals [12, 29, 31]. Additionally, survival to discharge rates for the Pumani device
which was noted in two studies ranged from 56 to 71% [5, 24] and for the improvised
water bottle system, the survival to discharge rate ranged from 52 to 85% over five
studies [12, 20, 22, 29, 34]. One study that did not describe the bubble CPAP system
they used reported a 42% survival rate and another study that surveyed multiple hospi-
tals where commercial models were the most frequently utilized device reported a 49%
survival rate [30]. Mechanical ventilation was not available on site in eight of the nine
studies and only one of these eight had the option of referring to a higher-level facility
with mechanical ventilation [31]. A survey in Kenya found that mechanical ventilation
was only available in 37% tertiary level hospitals across the nation [30].
Across the various forms of bubble CPAP systems, there were no major complica-
tions reported. Studies highlighted that this may be in part due to a lack of necessary
resources to assess for these complications such as routine x-rays, cranial ultrasounds
or autopsies to ascertain the cause of death [5, 23, 30]. Nasal and facial irritation was
the most commonly reported minor complication across different bubble CPAP sys-
tems and facility levels. For example, nasal irritation was reported in 14% of cases in a
secondary level facility with an improvised water bottle system [29], 13% of neonates
initially started on bubble CPAP in a tertiary level facility with a low-cost standalone
model (Pumani) [5] and 13% of infants in a multi-sited study with both tertiary and
secondary level facilities with a commercial model [32]. Nasal irritation was not well
defined but some studies described it as slight soreness, abrasions, swelling, redness
and mucosal erosion [29, 34].
Discussion
The purpose of the review was to evaluate the barriers and facilitators to implementing
bubble CPAP for newborn care at sub-Sahara African health facilities. Reliable avail-
ability of equipment, difficulties engaging and informing caregivers and staffing short-
ages were frequently mentioned barriers to the implementation of bubble CPAP.
Understaffed neonatal units and high turnover of nurses and doctors limited capacity
for care and was associated with gaps in training, which subsequently impacted initi-
ation, monitoring and weaning. Provider-to-provider clinical mentorship models were
identified as frequently mentioned facilitators of bubble CPAP implementation within
the context of staffing shortages and high staff turnovers as they helped to address chal-
lenges in the aim to formally train and retain trained staff in neonatal units. Affordabil-
ity and cost-effectiveness were also highlighted as important facilitators, especially for
low-cost standalone units and improvised models. A cost-effectiveness study on the
low-cost standalone unit from Malawi found an average cost per patient on bubble
CPAP was US$29.29 compared to US$57.78 per patient on nasal oxygen [27]. Mechan-
ical ventilation costs in LMICs was not available, though a study in the USA found that
costs for a preterm infant ≤ 32 weeks gestation on mechanical ventilation in the USA
was US$51,000–209,000 [35].
A previous review revealed that bubble CPAP may reduce the need for mechanical
ventilation in LMICs [8]. This is of great importance in resource-constrained contexts
where mechanical ventilation is not often available due to high costs, maintenance de-
mands and the need for highly trained staff. However, to use mechanical ventilation as
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a comparator to evaluate bubble CPAP excludes the most resource-constrained con-
texts where mechanical ventilation is unavailable. Such criteria would exclude almost
all of the studies in the present review, for example. The tertiary hospitals in sub-
Saharan Africa covered by the studies in this review frequently lacked the resources for
mechanical ventilation, which suggests that differences between LMICs may be just as
important as those between HICs and LMICs. A focus on low-resource settings is par-
ticularly important as bubble CPAP is being scaled-up to secondary level rural district
hospitals in sub-Saharan Africa where contexts may be even more resource-
constrained.
Secondary objectives of this review investigated how different facility levels and types
of bubble CPAP systems may impact utilization, expanding on previous reviews on the
efficacy of CPAP in LMICs where multiple types of nasal CPAP systems and health fa-
cility levels were grouped together [8, 9]. Few major complications were reported re-
gardless of the system type and facility setting and survival to discharge rates appeared
to differ more between studies than between the device used and the setting. The stud-
ies in this review, however, revealed contextual differences that could influence imple-
mentation and sustainability. Though many studies were conducted in tertiary level
facilities, two of the four studies completed in secondary level facilities highlighted how
decision-making aids were feasible and helpful to support nurses’ decision to initiate an
infant on bubble CPAP and to monitor the neonates’ level of respiratory distress. The
discussion around decision-making aids was absent in studies conducted in tertiary
level facilities perhaps in part because the tertiary level facilities had full-time paediatric
specialists on staff to make major decisions whereas the nurseries in secondary level fa-
cilities were often nurse-led [31].
Sub-Saharan Africa is unique in the global CPAP landscape for the development of
novel, low-cost standalone bubble CPAP systems in an attempt to reduce cost and
bridge the gap between conventional commercial models and locally improvised sys-
tems. Though less expensive than mechanical ventilation, conventional commercial
bubble CPAP systems cost between US$6000 and 18,000, which means that they con-
tinue to be unaffordable for resource-constrained hospitals in sub-Saharan Africa [5,
21, 23]. Additionally, most commercial systems available in these settings were donated
without the means to maintain them sustainably [30]. Both studies in the review using
conventional commercial systems involved external partners that brought in foreign
consultants to initially train and set up the programme [28, 32]. Maintenance and
programme sustainability for the commercial systems were key barriers after the donors
withdrew support and the presence of different types of bubble CPAP system made it
challenging for staff to be adequately trained for all the different devices and have all of
the components to set up and expertise in equipment maintenance for the various sys-
tems [30, 32]. With concerns around equipment maintenance and sustainability for the
commercial bubble CPAP system, both low-cost standalone models highlighted the af-
fordability and low maintenance of their systems as valuable facilitators to their imple-
mentation in sub-Saharan Africa [5, 21].
While innovative, low-cost, standalone models sought to present solutions to barriers
of affordability and maintenance, studies also revealed the basic necessity for a support-
ive health system environment. Understaffed neonatal units, gaps in training and short-
ages of ancillary supplies, such as disposable nasal prongs and oxygen concentrators,
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continued to provide significant challenges. In this, the situation with bubble CPAP is
not unique. The need for adequate supplies, financing, trained health workers and ser-
vice delivery coherence within and between health facilities has also been highlighted
as health system barriers in the scale-up of other maternal and child health interven-
tions across sub-Saharan Africa [36–38]. These barriers hinder the sustainability of
health interventions after implementation, particularly in sub-Saharan Africa where
there is a disproportionate share of the global disease burden and weak health systems
sensitive to the fluctuations of donor-funding [37]. For the implementation of bubble
CPAP and other neonatal care innovations, there is a need to consider health systems
and understand the challenges a low-resource setting presents in providing care for a
neonate including the processes involved and other factors that may impact the new-
born’s health. A retrospective analysis of the non-randomized controlled trial in
Malawi, for example, found that for survival outcomes, bubble CPAP was not sufficient
as a single intervention if a preterm neonate was hypothermic in addition to respiratory
distress [39]. The persistently high mortality rates reported in the neonatal bubble
CPAP studies in this review underlines the importance of health system strengthening
and the human and material resources required to improve care outcomes for small
and sick newborns. Even though the study population was different, the study by
McCollum et al. illustrates this point further [40]. In a large trial involving 644 older in-
fants and children up to 6 years of age, McCollum et al. found no reduction in hospital
mortality with bubble CPAP use (Fisher & Paykel commercial device) in a rural Mala-
wian hospital that did not have daily physician supervision [40]. For effective imple-
mentation of bubble CPAP, comprehensive quality care is needed in addition to
appropriate technologies.
One limitation of this review is the exclusion of non-English texts, which may
have excluded some studies. A strength of this review includes the use of multiple
reviewers, the searches on multiple databases and grey literature and use of quality
assessments. Similar to previous systematic reviews on CPAP and bubble CPAP
across LMICs, the present review did not find any randomized controlled trials [8,
9]. However, considering the strong recommendation for its use with preterm new-
borns in respiratory distress by the WHO [7] and neonatal experts in the field
[41], it is unethical to withhold treatment in order to conduct an RCT comparing
bubble CPAP and nasal oxygen therapy. There are grounds, however, to suggest
that other RCTs would be beneficial in developing a robust evidence-base for the
facilitators, such as an RCT assessing survival outcomes from bubble CPAP use in
addition to provided nursing utilization guidelines compared to bubble CPAP with
no utilization guidelines.
The quality assessment revealed that many studies had considerable risk of biases
(see Additional file 2) but unlike the previous systematic reviews published on bubble
CPAP [8, 9], the primary purpose of this review was not to evaluate efficacy. Some of
the implementation challenges around staffing shortages, training gaps and missing
data may introduce bias into studies; however, from an implementation science per-
spective, they importantly revealed health system barriers and facilitators. Research that
focuses on barriers and facilitators of implementation and utilization as the primary ob-
jective is needed, especially to understand the views of health professionals that interact
with bubble CPAP provisioning and oversight.
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Conclusion
To accelerate progress towards the reduction of neonatal mortality in sub-Saharan Af-
rica, improvements in neonatal care is needed, especially for premature newborns.
There has been increasing interest in the utilization of bubble CPAP in resource-
constrained health facilities in sub-Saharan Africa to improve outcomes for neonates
with respiratory distress. However, the implementation of bubble CPAP is not without
its challenges. While bubble CPAP may be seemingly streamlined and uncomplicated
compared to mechanical ventilation, even simple and innovative technologies require
supportive health systems for effective implementation and utilization. Future research
into health system barriers and facilitators of bubble CPAP implementation is para-
mount for practical purposes, especially in low-resource and rural contexts.
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